(FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q9)Sep 30, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 148.71%9.91M | 133.54%6.89M | 166.85%5.31M | 547.72%2.99M | -28.82%3.98M | -18.85%2.95M | 7.17%1.99M | -53.67%461K | 5.09%5.6M | -26.08%3.63M |
Operating income | 148.71%9.91M | 133.54%6.89M | 166.85%5.31M | 547.72%2.99M | -28.82%3.98M | -18.85%2.95M | 7.17%1.99M | -53.67%461K | 5.09%5.6M | -26.08%3.63M |
Operating expenses | ||||||||||
Gross profit | ||||||||||
Selling expenses | 61.29%-24K | 51.16%-21K | 21.74%-18K | 0.00%-9K | -93.75%-62K | -95.45%-43K | -155.56%-23K | -50.00%-9K | -128.57%-32K | -144.44%-22K |
Employee expense | -23.28%-4.75M | -29.05%-3.81M | -41.37%-2.83M | -71.61%-1.71M | 9.11%-3.85M | 10.13%-2.95M | 12.34%-2M | 19.07%-997K | 37.47%-4.24M | 40.42%-3.29M |
Depreciation and amortization | -72.07%-499K | -124.85%-380K | -170.21%-254K | -180.85%-132K | 7.94%-290K | 37.17%-169K | 58.59%-94K | 68.24%-47K | 58.06%-315K | 54.48%-269K |
Revaluation surplus | 80.40%-267K | --160K | --108K | ---- | ---1.36M | ---- | ---- | ---- | ---- | ---- |
-Changes in the fair value of derivative financial instruments | 80.40%-267K | --160K | --108K | ---- | ---1.36M | ---- | ---- | ---- | ---- | ---- |
Impairment and provision | -257.56%-733K | 63.28%-65K | 63.28%-65K | ---- | -102.76%-205K | -102.33%-177K | -65.42%-177K | ---177K | 145.21%7.42M | 221.89%7.59M |
-Other impairment is provision | -257.56%-733K | 63.28%-65K | 63.28%-65K | ---- | -102.76%-205K | -102.33%-177K | -65.42%-177K | ---177K | 145.21%7.42M | 221.89%7.59M |
Special items of operating profit | -11.23%-604K | 42.80%-310K | 0.00%-181K | -512.90%-128K | 33.70%-543K | 31.65%-542K | 46.92%-181K | 381.82%31K | 50.96%-819K | 29.39%-793K |
Operating profit | 229.89%3.03M | 362.71%2.46M | 519.96%2.06M | 236.31%1.01M | -130.65%-2.33M | -113.65%-936K | 55.96%-491K | -83.58%-738K | 137.49%7.61M | 180.16%6.86M |
Financing cost | -575.82%-615K | -546.97%-427K | -578.57%-285K | -554.55%-144K | 2.15%-91K | 5.71%-66K | 10.64%-42K | 4.35%-22K | -151.35%-93K | -438.46%-70K |
Earning before tax | 199.63%2.41M | 302.79%2.03M | 433.40%1.78M | 213.42%862K | -132.24%-2.42M | -114.76%-1M | 54.13%-533K | -78.82%-760K | 136.97%7.52M | 179.22%6.79M |
Tax | -138.38%-677K | ---357K | ---339K | ---181K | -425.93%-284K | ---- | ---- | ---- | -180.60%-54K | -157.14%-18K |
After-tax profit from continuing operations | 164.17%1.74M | 267.17%1.68M | 369.79%1.44M | 189.61%681K | -136.28%-2.71M | -114.80%-1M | 54.13%-533K | -78.82%-760K | 136.82%7.46M | 178.95%6.77M |
Earning after tax | 164.17%1.74M | 267.17%1.68M | 369.79%1.44M | 189.61%681K | -136.28%-2.71M | -114.80%-1M | 54.13%-533K | -78.82%-760K | 136.82%7.46M | 178.95%6.77M |
Profit attributable to shareholders | 164.17%1.74M | 267.17%1.68M | 369.79%1.44M | 189.61%681K | -136.28%-2.71M | -114.80%-1M | 54.13%-533K | -78.82%-760K | 136.82%7.46M | 178.95%6.77M |
Basic earnings per share | 164.29%0.0009 | 260.00%0.0008 | 333.33%0.0007 | 175.00%0.0003 | -137.84%-0.0014 | -114.71%-0.0005 | 50.00%-0.0003 | -100.00%-0.0004 | 136.63%0.0037 | 179.07%0.0034 |
Diluted earnings per share | 164.29%0.0009 | 260.00%0.0008 | 333.33%0.0007 | 175.00%0.0003 | -137.84%-0.0014 | -114.71%-0.0005 | 50.00%-0.0003 | -100.00%-0.0004 | 136.63%0.0037 | 179.07%0.0034 |
Currency Unit | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD | SGD |
Accounting Standards | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS | IAS |
Audit Opinions | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- |
Auditor | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data